JP2015163614A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015163614A5 JP2015163614A5 JP2015075416A JP2015075416A JP2015163614A5 JP 2015163614 A5 JP2015163614 A5 JP 2015163614A5 JP 2015075416 A JP2015075416 A JP 2015075416A JP 2015075416 A JP2015075416 A JP 2015075416A JP 2015163614 A5 JP2015163614 A5 JP 2015163614A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- agent according
- famciclovir
- treatment agent
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims description 8
- 238000007911 parenteral administration Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 10
- 229960004396 famciclovir Drugs 0.000 claims 7
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 claims 7
- 208000004898 Herpes Labialis Diseases 0.000 claims 3
- 206010067152 Oral herpes Diseases 0.000 claims 3
- 230000000306 recurrent effect Effects 0.000 claims 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 claims 1
- -1 4-acetoxy-3-acetoxymethylbut-1-yl Chemical group 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- BRPTUOYNOCSFRJ-FYZOBXCZSA-N sodium (2S)-4-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)butan-1-olate Chemical class [Na+].Nc1nc(=O)c2ncn(CC[C@H](CO)C[O-])c2[nH]1 BRPTUOYNOCSFRJ-FYZOBXCZSA-N 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66653605P | 2005-03-30 | 2005-03-30 | |
| US60/666,536 | 2005-03-30 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012232172A Division JP6018473B2 (ja) | 2005-03-30 | 2012-10-19 | １日１回処置を使用する再発性口唇ヘルペスの処置のためのファムシクロビル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015163614A JP2015163614A (ja) | 2015-09-10 |
| JP2015163614A5 true JP2015163614A5 (enExample) | 2016-10-20 |
Family
ID=36829888
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008504316A Withdrawn JP2008534603A (ja) | 2005-03-30 | 2006-03-29 | １日１回処置を使用する再発性口唇ヘルペスの処置のためのファムシクロビル |
| JP2012232172A Expired - Fee Related JP6018473B2 (ja) | 2005-03-30 | 2012-10-19 | １日１回処置を使用する再発性口唇ヘルペスの処置のためのファムシクロビル |
| JP2015075416A Withdrawn JP2015163614A (ja) | 2005-03-30 | 2015-04-01 | １日１回処置を使用する再発性口唇ヘルペスの処置のためのファムシクロビル |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008504316A Withdrawn JP2008534603A (ja) | 2005-03-30 | 2006-03-29 | １日１回処置を使用する再発性口唇ヘルペスの処置のためのファムシクロビル |
| JP2012232172A Expired - Fee Related JP6018473B2 (ja) | 2005-03-30 | 2012-10-19 | １日１回処置を使用する再発性口唇ヘルペスの処置のためのファムシクロビル |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20100298353A1 (enExample) |
| EP (2) | EP2363131A1 (enExample) |
| JP (3) | JP2008534603A (enExample) |
| KR (1) | KR101312820B1 (enExample) |
| CN (1) | CN101678028A (enExample) |
| AT (1) | ATE545419T1 (enExample) |
| AU (3) | AU2006230269A1 (enExample) |
| BR (1) | BRPI0609793A2 (enExample) |
| CA (1) | CA2602641A1 (enExample) |
| ES (1) | ES2382664T3 (enExample) |
| PL (1) | PL1865961T3 (enExample) |
| PT (1) | PT1865961E (enExample) |
| RU (2) | RU2007139762A (enExample) |
| TW (1) | TW200716124A (enExample) |
| WO (1) | WO2006105194A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006230269A1 (en) * | 2005-03-30 | 2006-10-05 | Novartis Ag | Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3485225D1 (de) | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
| DE3582399D1 (de) | 1984-09-20 | 1991-05-08 | Beecham Group Plc | Purin-derivate und ihre pharmazeutische verwendung. |
| DE3671227D1 (de) | 1985-07-27 | 1990-06-21 | Beecham Group Plc | 9-substituierte guaninmonohydrate. |
| GB8628826D0 (en) | 1986-12-02 | 1987-01-07 | Beecham Group Plc | Pharmaceutical products |
| US5840763A (en) * | 1994-12-12 | 1998-11-24 | Smithkline Beecham Plc | Treatment of a latent infection of herpes viruses |
| RU2179849C2 (ru) * | 1999-07-27 | 2002-02-27 | Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии | Способ лечения рецидивирующего генитального герпеса у женщин |
| RU2178699C1 (ru) * | 2001-04-04 | 2002-01-27 | Змызгова Анна Васильевна | Способ лечения герпесовирусных инфекций, включающий озонотерапию |
| AU2006230269A1 (en) * | 2005-03-30 | 2006-10-05 | Novartis Ag | Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
-
2006
- 2006-03-28 AU AU2006230269A patent/AU2006230269A1/en not_active Abandoned
- 2006-03-29 EP EP10179668A patent/EP2363131A1/en not_active Withdrawn
- 2006-03-29 EP EP06739956A patent/EP1865961B1/en active Active
- 2006-03-29 RU RU2007139762/14A patent/RU2007139762A/ru unknown
- 2006-03-29 PL PL06739956T patent/PL1865961T3/pl unknown
- 2006-03-29 KR KR1020077024918A patent/KR101312820B1/ko not_active Expired - Fee Related
- 2006-03-29 ES ES06739956T patent/ES2382664T3/es active Active
- 2006-03-29 WO PCT/US2006/011460 patent/WO2006105194A2/en not_active Ceased
- 2006-03-29 JP JP2008504316A patent/JP2008534603A/ja not_active Withdrawn
- 2006-03-29 PT PT06739956T patent/PT1865961E/pt unknown
- 2006-03-29 TW TW095110943A patent/TW200716124A/zh unknown
- 2006-03-29 RU RU2007139758/15A patent/RU2432951C2/ru active
- 2006-03-29 CA CA002602641A patent/CA2602641A1/en not_active Abandoned
- 2006-03-29 AT AT06739956T patent/ATE545419T1/de active
- 2006-03-29 AU AU2006230291A patent/AU2006230291A1/en not_active Abandoned
- 2006-03-29 BR BRPI0609793-6A patent/BRPI0609793A2/pt not_active IP Right Cessation
- 2006-03-29 CN CN200680010840A patent/CN101678028A/zh active Pending
-
2010
- 2010-05-06 AU AU2010201834A patent/AU2010201834B2/en not_active Expired - Fee Related
- 2010-07-01 US US12/803,649 patent/US20100298353A1/en not_active Abandoned
-
2011
- 2011-12-20 US US13/330,979 patent/US20120088781A1/en not_active Abandoned
-
2012
- 2012-09-06 US US13/604,955 patent/US20120329814A1/en not_active Abandoned
- 2012-10-19 JP JP2012232172A patent/JP6018473B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-14 US US14/252,514 patent/US20150005324A1/en not_active Abandoned
-
2015
- 2015-04-01 JP JP2015075416A patent/JP2015163614A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2739459T3 (es) | Una composición estable que comprende una proteína anabólica ósea, es decir un análogo de PTHrP y usos de la misma | |
| ES2594557T3 (es) | Composiciones farmacéuticas | |
| JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
| ES2584190T1 (es) | Proceso para la fabricación de una preparación farmacéutica que contiene acetato de glatiramero | |
| PE20170302A1 (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington | |
| HRP20240485T1 (hr) | Pripravci glp-1 i njihova upotreba | |
| JP2019515908A5 (enExample) | ||
| ECSP055970A (es) | Uso de palonosetron para el tratamiento de nausea y vomito post operatorio | |
| JP2016539921A5 (enExample) | ||
| JP2019194227A (ja) | ビオプテリン誘導体を含む固体薬学的組成物およびそのような組成物の使用 | |
| HRP20230929T1 (hr) | Stabilni pripravci semaglutida i njihova upotreba | |
| KR20170056702A (ko) | 지효성 약제학적 조성물 | |
| ES2731526T3 (es) | Solución farmacéutica de Pemetrexed | |
| PT1885333E (pt) | Formulação farmacêutica de apomorfina para administração bucal | |
| ES2402864T3 (es) | Prevención de infección por VIH con TMC278 | |
| JP2015163614A5 (enExample) | ||
| HRP20161634T1 (hr) | Novi pripravak alfentanila za liječenje akutne boli | |
| HRP20210418T1 (hr) | Liječenje s syd985 pacijenata s rakom koji ne reagira na t-dm1 | |
| JP2013049687A5 (enExample) | ||
| US11723978B2 (en) | Ganciclovir compositions and related methods | |
| RU2018114922A (ru) | Лечение очаговой алопеции | |
| WO2016086327A1 (es) | Formulación antioxidante inyectable de uso intravenoso de ascorbato de sodio - en altas dosis, n-acetilcisteína, y deferoxamina; método de administración y uso en prevenir daño por reperfusión; y kit | |
| ES2629103T3 (es) | Formulación en polvo de valganciclovir | |
| BRPI0606119B1 (pt) | Preparações injetáveis de diclofenaco e seus sais farmaceuticamente aceitáveis | |
| RU2015111491A (ru) | Комбинация макроциклического ингибитора протеазы hcv, ненуклеозидного ингибитора hcv и ритонавира |